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the prescribing physician’s response. The pharmacists evaluated
the clinical signiﬁcance of the interventions based on their own
clinical judgments. Analyses were performed using descriptive
statistics. RESULTS: A total of 504 interventions were docu-
mented over the 5-month study period. On average each inter-
vention took 15  14 (median, 10) minutes, ranging from 1
minute to 3 hours. The most common interventions performed
were on drug regimen change (n = 237; 47%), drug choice
(n = 128; 25%) and drug information issues (n = 106; 21%).
Dose change (n = 153; 30%) and patient education (n = 54;
11%) were the most frequent interventions performed in the
drug regimen change and drug information categories, respec-
tively. The most common indications for which interventions
were made were infectious (n = 100; 20%) and respiratory
(n = 77; 15%) diseases. Efﬁcacy was improved and toxicity
avoided in 38% (n = 193) and 28% (n = 140) of the interven-
tions, respectively. Potential fatalities or end-organ damage was
avoided in 1.6% (n = 8) of the cases while interventions of major
signiﬁcance was recorded in 43% (n = 215) of the interventions.
CONCLUSIONS: The data show that clinical pharmacists play
an important role in drug safety and efﬁcacy to optimize phar-
maceutical care as part of the multi-disciplinary team approach
in the hospital.
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OBJECTIVES: To evaluate the operation of the Afternoon Out-
patients Clinics (AOC) at the University General Hospital of
Larissa. The operation of AOC is a relatively new institution in
the country, introduced in 2001 by the 2889 NHS reform law.
METHODS: Descriptive and comparative analysis of data from
2002 of the AOC introduction up to 2006 is done. Data emanate
from the 5th Region Health Authority. Clinical and economic
indicators have been used for the evaluation based on medical
specialties, diagnostic and professional categories, operational
activities and ﬁnancial inputs and outputs. RESULTS: A progres-
sive increase in AOC visits has been estimated, reaching 82% of
total hospital outpatient visits with surgery accepting the bigger
volume of visits. Their income presents a 12.6% mean annual
increase while expenses reached 17.9% respectively. Financial
resources of surgical cases increased 63% and pathological 25%
over the period 2002–2006, with a 27% income increase of
gynaecological AOC 21% of orthopaedics and 7% of ophthal-
mologic. Social funds do not reimburse AOC visits and patients’
out of pocket payments are the main sources of the AOC
funding. CONCLUSIONS: The operation of the AOC is encour-
aging, since it motivates health professionals to increase their
income, the hospital to exploit its full potential, offers patients
access to quality health care and covers unmet needs. The fact
that the operation of the AOC is based on patients’ direct pay-
ments remains a contradiction with the full coverage of the Greek
population for the provision of outpatient and impatient care in
the public sector. The lack of contracting negotiations between
the social insurance funds and the regional or hospital authorities
remains a problem for which the state owes to make policy
decisions, since the prices that are overwhelmed are almost com-
petitive to the private sector and overload disproportionately the
lower incomes.
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OBJECTIVES: To register the opinions of the employees as con-
cerned the supply chain management, which has been adopted
from hospitals. METHODS: Data were collected via a question-
naire and were processed by using the logistic regression method.
A total of 250 people were asked, all employees of health care
industry. RESULTS: Only 6.5% of the employees knows the cost
of the materials they use and 82.2% of them state that if they
were aware of the cost of the materials, they would certainly use
them more wisely. Also, 55.1% of the survey participants were
dissatisﬁed with the supply chain procedure and 55.6% would
rather each clinic or laboratory managed its supplying by itself.
Finally, 59.2% of the employees believes that there are no incen-
tives and control as far as hospital’s supply chain management.
CONCLUSIONS: There is a pressing need for the Greek hospi-
tals to re-organize their supply chain management in order to
reduce cost and offer quality health care.
PHP44
INEQUALITIES INTHE FINANCING OF DRUGS AMONG
AUTONOMOUS REGIONS IN SPAIN
Badia X,Vieta A
IMS Health, Barcelona, Spain
OBJECTIVES: To identify and analyse differences in the ﬁnanc-
ing of drugs between Autonomous Regions (AR) in Spain.
METHODS: A structured literature review on the IME, SciELO,
Doyma, Medline, Cochrane, national and AR ofﬁcial bulletins,
relevant Spanish scientiﬁc associations and AR health web pages,
and general and specialised press, up to June 15, 2007.RESULTS:
Nine AR legislative documents were identiﬁed, one national
working document, two press releases, one AR instruction, four
scientiﬁc articles and twoministerial documents. The most impor-
tant ﬁndings are as follows. Navarre and Andalusia ﬁnance some
drugs excluded from national public funding by the Royal Decree
1663/1998. Navarre, La Rioja, Extremadura and Madrid ﬁnance
smoking cessation products for the general population whereas
Cantabria and Catalonia only to some population groups. The
postcoital pill is ﬁnanced in Andalusia, Cantabria, Catalonia,
Canary Islands, Aragon, Asturias and Galicia. Erectile dysfunc-
tion drugs for patients with medullar damage are ﬁnanced in
Valencia, Murcia, Balearic Islands and Castile la Mancha. Differ-
ences have been detected in the ﬁnancing level (reduced co-
payment or free of charge) of several drugs for speciﬁc population
groups. Castile Leon has a reduced co-payment in antiviral and
antifungal drugs for cancer patients. Extremadura ﬁnances the
totality of the drugs to chronic patients younger than 14 years old
and families with more than 3 children, and Valencia ﬁnance total
treatment costs of tuberculosis drugs.CONCLUSIONS:There are
differences in the ﬁnancing of various pharmaceutical products
with low intrinsic value, life-style drugs and preventive drugs.
These inequalities may be perceived as a reason of inequity or may
reﬂect the intention to redistribute health care resources among
AR’s preferences. It is necessary to evaluate the preferences of the
population and the way these differences affect their health status.
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OBJECTIVES: Orphan medicinal product legislation was
adopted in Europe in 2000 with the aim of promoting the devel-
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